🩸Additional facts about transplantation & curative intent in Myelofibrosis

#Myelofibrosis #MF #Hematology #Spleen #BloodCancer #JAKInhibitors #Engraftment #AML #Hematopoiesis #BoneMarrowFibrosis #PatientCare #BloodDisorders #MedEd #HEMEHUB

🩸 Happening next week!

Register: hemehub.org/live-webinars
Submit your cases: hemehub.org/case-submiss...

#Myelofibrosis #MPN #Hematology #BloodCancer #JAKInhibitors #BoneMarrow #Transplantation #HemeHub #BloodDisorders @mayocliniccancer.bsky.social @mayoclinic.org

🩸Today’s questions!

Swipe to see the answers and their explanations.

#Myelofibrosis #MF #Hematology #HemeOnc #HematologyEducation #MedEd #MedicalEducation #ClinicalTrials #JAKInhibitors #Momelotinib #Ruxolitinib #SIMPLIFY1 #ASH #HemeHub @ash.edu.hematology.org @ash.hematology.org

🩸Facts about Myelofibrosis:

Combination & Emerging Therapies

#Myelofibrosis #HemeOnc #Hematology #MedEd #ClinicalTrials #Epigenetics #Pelabresib #Ruxolitinib #JAKInhibitors #Selinexor #NFkB #Cytokines #HemeHub #HematologyEducation #MedicalEducation

🩸 Happening next week!

🔗Register: hemehub.org/live-webinars
💬Case submissions: hemehub.org/case-submiss...

#Myelofibrosis #MPN #Hematology #BloodCancer #JAKInhibitors #BoneMarrow #Transplantation #HemeHub #PatientCare #MedicalEducation #BloodDisorders @mayocliniccancer.bsky.social @mayoclinic.org

🩸 Additional insights on JAK inhibitor therapy in myelofibrosis

#Myelofibrosis #MF #Hematology #HemeOnc #JAKInhibitors #Momelotinib #Ruxolitinib #Fedratinib #Pacritinib #Thrombocytopenia #Platelets #JAKiDiscontinuation #ClinicalTrials #SIMPLIFY2Trial #MedEd #BloodDisorders #MPN #HEMEHUB

JAK inhibitors: risks and safety principles Introduction The Janus kinases (JAKs) are protein tyrosine kinases that mediate cellular responses to several cytokines and growth factors, which play a role in immune defence and immune-mediated…

*JAK inhibitors: risks and safety principles*

An overview of the mechanism of action of JAK inhibitors, as well as the risks and common side effects of their use in treating chronic inflammatory disorders

#JAKinhibitors #inflammatorydisorders

🩸Today’s questions!

Swipe to see the answers and their explanations!

#Myelofibrosis #MPN #Hematology #HemeOnc #Ruxolitinib #Selinexor #Pelabresib #JAKInhibitors #Hepcidin #Erythropoiesis #Splenomegaly #BoneMarrow #BloodDisorders #MedEd #ClinicalHematology #MPNResearch #BloodCancer #HEMEHUB

🩸Facts about Myelofibrosis:

JAK Inhibitor Therapy

#Myelofibrosis #MPN #Hematology #JAKInhibitors #Ruxolitinib #Momelotinib #ACVR1 #Hepcidin #Erythropoiesis #Splenomegaly #BoneMarrow #BloodDisorders #ClinicalHematology #MedEd #HemeOnc #HEMEHUB
@gmpnsf.bsky.social @rarediseaseadvisor.bsky.social

🩸 Don’t miss our upcoming session on myelofibrosis featuring Ayalew Tefferi, MD, and Taha Bat, MD!

🔗Register: hemehub.org/live-webinars
💬Submit your cases: hemehub.org/case-submiss...

#Myelofibrosis #MPN #Hematology #JAKInhibitors #BoneMarrow #HemeHub @mayocliniccancer.bsky.social @mayoclinic.org

Janus Kinases JAKs Inhibitor Drug Market Growth Report 2035 Janus Kinases JAKs Inhibitor Drug Market growth is projected to reach USD 25.77 Billion, at a 13.72% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast ...

💊 JAK Inhibitors Market grows with adoption in autoimmune treatments. Report: www.marketresearchfuture.com/reports/janu... #JAKInhibitors #Pharma

The Patch talks about youth resilience, the power and limits of different types of knowledge, 3 decades before the discovery that alopecia areata is an #autoimmunedisease.

It is written with lightness and precision. It's fiction, but it tells scientific truth.

#jakinhibitors in the footnotes

New Prognostic Model Developed for Myelofibrosis Transplant Outcomes The new AI-based model is designed to improve on existing tools for predicting outcomes in patients with MF undergoing allo-HCT.

Researchers have developed a novel, comprehensive, machine learning-based prognostic model to predict post-transplant outcomes in patients with #Myelofibrosis (MF) who have received Janus kinase (#JAK) inhibitors.

Read here: https://bit.ly/3LY62lw

#RareDisease #JAKInhibitors #MedSky

What are JAK inhibitors and how do they work? Official answer: Janus kinase (JAK) inhibitors are a group of medicines that help block immune system signals in the body that can lead...

#JAKInhibitors block immune signals causing inflammation in rheumatoid arthritis, ulcerative colitis, and psoriatic arthritis. Available orally or topically, they're DMARDs that slow joint damage. Xeljanz was the first FDA-approved JAK inhibitor in 2012.

#AlopeciaAreata #HairLossTreatment #Dermatology #JAKInhibitors #SkinCareNetwork #HairRestoration #MedicalDermatology

JAK inhibitors for the treatment of palmoplantar pustulosis: a narrative review - Drugs in Context This narrative review evaluates current evidence on the efficacy and safety of JAK inhibitors in the treatment of palmoplantar pustulosis.

💊 JAK inhibitors for the treatment of palmoplantar pustulosis: a narrative review

Henriques dos Santos et al.

@drugsincontext.bsky.social #dermatology #JAKinhibitors #biologics #MedSky #PharmSky

www.drugsincontext.com/jak-inhibito...

There is currently no robust #clinicaltrial data confirming ruxolitinib's effectiveness for the complexity range of symptoms associated with #LongCOVID due to
- A significant concern with #JAKinhibitors is their immunosuppressive effect,

#Medsky🧪 #IDsky #pharmasky #Publichealth This IPDMA of RCTs in adults admitted to 🏥 due to #COVID, #JAKinhibitors reduced mortality across all levels of respiratory support, independent of #dexamethasone or #tocilizumab & probably decreased serious & severe adverse events vs with no JAK inhibitors.

Upadacitinib for the treatment of radiographic axial spondyloarthritis — case series and review of the literature - Drugs in Context Four case studies described here illustrate the effectiveness of upadacitinib in a range of real-world patients with axial spondyloarthritis.

📣 New in @drugsincontext.bsky.social

Upadacitinib for the treatment of radiographic axial spondyloarthritis — case series and review of the literature

Lopalco et al.

#drugsincontext #rheumatology #JAKinhibitors #pharmacology #MedSky #PharmSky

www.drugsincontext.com/upadacitinib...

JAKinibs to the rescue!!!
#ImmunoSky #JAKinhibitors

In a recent episode of the Evidence Based Hair Podcast, I discussed the safety of JAK inhibitors in pregnancy. m.youtube.com/watch?v=-Zap... #alopeciaareata #jakinhibitors #ritlecitinib #baricitinib #tofacitinib

Researchers uncover the potential of JAK inhibitors to treat life-threatening skin disease Researchers identified Janus kinase inhibitors as a promising treatment for the severe drug-induced skin condition toxic epidermal necrolysis, by analyzing patient biopsies with deep visual proteomics...

Researchers uncover the potential of JAK inhibitors to treat life-threatening skin disease 🔬🧬💉 www.news-medical.net/news/2024101... #JAKInhibitors #SkinDisease #Medical #Proteomics #DrugReactions #Biotech #Research #Inflammation @natureportfolio.bsky.social

Janus Kinase Inhibitors | COVID-19 Treatment Guidelines Review information on the use of Janus kinase inhibitors for the treatment of COVID-19.

Several #JAKinhibitors are available for clinical use, but only #baricitinib & #tofacitinib have been studied for the treatment of #COVID19.

www.covid19treatmentguidelines.nih.gov/therapies/im...

A specific phosphorylation-dependent conformational switch in SARS-CoV-2 nucleocapsid protein inhibits RNA binding Phosphorylation of SARS-CoV-2 nucleocapsid protein induces conformational changes that inhibit RNA binding and release bound RNA.

#MedSky🧪#IDSky #JAKinhibitors are used to treat #COVID19 because they can prevent phosphorylation of key proteins involved in the signal transduction that leads to immune activation and inflammation (e.g cellular response to proinflammatory cytokines such as IL6)

www.science.org/doi/10.1126/...